A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.

计划入组 27 人 · 首次发布于 2013 年 2 月 7 日

A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth

计划入组 13 人 · 首次发布于 2012 年 8 月 10 日

BN83495 Phase I in Post-menopausal Women

计划入组 50 人 · 首次发布于 2013 年 4 月 25 日

Irosustat

C₁₄H₁₅NO₅S

EGFR Target siRNA(IROST)

Iron(Citranatal B-calm Kit, Citranatal Harmony, Concept Ob, Ferralet 90, Natafort, Vitafol-one)

<dd class="col-xl-8 col-md-9 col-sm-8">Fe</dd>

ICOS Corporation

United States

Iris Sommer

Germany

Aros Pharma ApS

Denmark

IROS and Halia Therapeutics Launch Pioneering Obesity Clinical Trial in UAE

vTv Therapeutics Initiates Phase 2 Trial of Cadisegliatin for Type 2 Diabetes in Middle East and North Africa

UAE's Clinical Trial Landscape Matures with Government Support and Genomic Initiatives